![N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine](https://static.cymitquimica.com/products/3D/img/FM43363.png "Cliccare per ingrandire")
N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine
CAS: 1025065-69-3
Rif. 3D-FM43363
| 5mg | 436,00 € | ||
| 10mg | 711,00 € | ||
| 25mg | 1.449,00 € | ||
| 50mg | 2.609,00 € |
Informazioni sul prodotto
- N-[(1-Methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine sulfate
- SGI-1776
N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine (NCTA) is a novel anticancer drug that has been shown to be effective against cancer cells in vitro and in vivo. NCTA inhibits the transcriptional activation of cyclin D2, which is essential for the growth and survival of cancer cells. It also inhibits osteoclast formation, which leads to decreased bone resorption. NCTA has not yet been tested in humans but its clinical relevance has been demonstrated in animal models. The drug's protein target is pim-1, a protein that regulates cell migration and proliferation.
Proprietà chimiche
Richiesta tecnica su: 3D-FM43363 N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
